2m 2m 2m 2m 2m 2m 2m
Corvus Pharmacet (CRVS)
NASDAQ
$14.53+$0.06 (+0.45%)
Price as of Aug 21, 2026 7:36 PM EDT- $1.2BMarket Cap
- 160.54%1-Year Change
- BiotechnologyIndustry
Corvus Pharmacet (CRVS)
$14.53+$0.06 (+0.45%)
CRVS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.46 | ||
Change | +$0.13 (+0.91%) | ||
Open | $14.52 | ||
High | $14.76 | ||
Low | $14.38 | ||
Previous Close | $14.33 | ||
Volume | 473,785 | ||
30-Day Average Volume | 801,951 | ||
1-Week Change | -2.89% | ||
1-Month Change | -0.07% | ||
1-Year Change | 160.54% | ||
3-Year Change | 557.27% | ||
5-Year Change | 657.07% | ||
Fundamentals | |||
Shares Outstanding | 84.1M | ||
Total Assets | $239.3M | ||
Market Cap | $1.2B | ||
Enterprise Value | $1.2B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$18.0M | ||
Free Cash Flow | -$16.0M | ||
EBIT | -$18.0M | ||
EBITDA | -$17.9M | ||
Net Working Capital | $207.3M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -67 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -76 | ||
PEG | 3 | ||
Price/Free Cash Flow | -76 | ||
Price/Operating Cash Flow | -79 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue